Document is current

Any future updates will be listed below

β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by targeting the RAC1/mTOR/TFEB axis thus activating lipophagy-lysosomal pathway

Crossref DOI link: https://doi.org/10.1038/s41401-025-01702-8

Published Online: 2026-01-07

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark